Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment

Behavior Therapy

Volumn 27, Issue 3, 1996, Pages 473-482

  Otto, Michael W ^a   Pollack, Mark H ^a   Sabatino, Susan A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

ADULT; AGORAPHOBIA; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; FEMALE; HUMAN; MALE; PANIC; REMISSION; TREATMENT OUTCOME;

EID: 0030479214     PISSN: 00057894     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-7894(96)80028-1     Document Type: Article

References (33)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.), Washington, DC: Author.
2. Barlow, D. H. (1988). Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford Press.
3. Beck, A. T., Sokol, L., Clark, D. A., Berchick, R,. & Wright, F. (1992). A crossover study of focused cognitive therapy for panic disorder. American Journal of Psychiatry, 149, 778-783.
4. Brown, T. A., Antony, M. M., & Barlow, D. H. (1995). Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychology, 63, 408-418.
5. Brown, T. A., & Barlow, D. H. (1995). Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. Journal of Consulting and Clinical Psychology, 63, 754-765.
6. Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P. A., & Gelder, M. (1994). A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry, 164, 759-769.
7. Clum, G. A. (1989). Psychological interventions vs. drugs in the treatment of panic. Behavior Therapy, 29, 429-457.
8. Clum, G. A., Clum, G. A., & Surls, R. (1993). A meta-analysis of treatments for panic disorder. Journal of Consulting and Clinical Psychology, 61, 317-326.
9. Craske, M. G., Brown, T. A., & Barlow, D. H. (1991). Behavioral treatment of panic: A two year follow-up. Behavior Therapy, 22, 289-304.
10. Ehlers, A. (1995). A 1-year prospective study of panic attacks: Clinical course and factors associated with maintenance. Journal of Abnormal Psychology, 104, 164-172.
11. Gould, R. A., Otto, M, W., & Pollack, M. H. (1995). A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review, 15, 819-844.
12. Hegel, M. T., Ravaris, C. L., & Ahles, T. A. (1994). Combined cognitive-behavioral and timelimited alprazolam treatment of panic disorder. Behavior Therapy, 25, 183-195.
13. Herjanic, B., & Reich, W. (1982). Development of a structured psychiatric interview for children: Agreement between child and parent. Journal of Abnormal Child Psychology, 10, 307-324.
14. Marks, I. M., & Mathews, A. M. (1979). Brief standard self-rating for phobic patients. Behaviour Research and Therapy, 17, 263-267
15. Marks, I. M., Swinson, R. R, Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., & Wickwire, K. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776-787.
16. Mavissakalian, M. (1990). Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia. Journal of Clinical Psychiatry, 51, 184-188.
17. Mavissakalian, M., & Michelson, L. (1986a). Agoraphobia: Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. Journal of Clinical Psychiatry, 47, 117-122.
18. Mavissakalian, M., & Michelson, L. (1986b). Two-year follow up of exposure in imipramine treatment of agoraphobia. American Journal of Psychiatry, 143, 1106-1112.
19. Mavissakalian, M., & Perel, J. M. (1992). Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Archives of General Psychiatry, 49, 318-323.
20. Noyes, R., Garvey, M. J., Cook, B. L., & Samuelson, L. (1989). Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: Results of a naturalistic follow-up study. Journal of Clinical Psychiatry, 50, 163-169.
21. Noyes, R., Garvey, M. J., Cook, B., & Suelzer, M. (1991). Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517-523.
22. Otto, M. W., & Gould, R. A. (1996). Maximizing treatment outcome for panic disorder: Cognitive-behavioral strategies. In M. H. Pollack, M. W. Otto, & J. F. Rosenbaum (Eds.), Challenges in clinical practice: Pharmacologic and psychosocial strategies (pp. 113-140). New York: Guilford Press.
23. Otto, M. W., Pollack, M. H., & Barlow, D. H. (1995). Stopping anxiety medication: A workbook for patients wanting to discontinue benzodiazepine Treatment for panic disorder, Albany, NY: Graywind Publications.
24. Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S., & Rosenbaum, J. R (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavior therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.
25. Orvaschel, H., &. Puig-Antich, J. (1987). Schedule for affective disorder and schizophrenia for school age children (Epidemiologic version, 4th ed.). Fort Lauderdale, FL: Nova University Center for Psychological Study.
26. Peterson, R. A., & Reiss, S. (1992). Anxiety sensitivity index revised test manual. Worthington, OH: International Diagnostic Services, Inc.
27. Pollack, M. H., & Otto, M. W. (1994). Long-term pharmacologic treatment of panic disorder. Psychiatric Annals, 24, 291-298.
28. Pollack, M. H., Otto, M. W., Kaspi, S. P., Hammerness, P. G., & Rosenbaum, J. F. (1994). Cognitive-behavior therapy for treatment-refractory panic disorder. Journal of Clinical Psychiatry, 55, 200-205.
29. Sanderson, W. C., & Wetzler, S. (1993). Observations on the cognitive behavioral treatment of panic disorder: Impact of benzodiazepines. Psychotherapy, 30, 125-132.
30. Spiegel, D. A., Bruce, T. J., Gregg, S. F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry, 151, 876-881.
31. Spitzer, R. L., Williams, J. B. W., & Gibbon, M. (1988). Structured Clinical Interview for DSM III-R-Upjohn Version-Revised (SCID-UP-R). New York: Biometrics Research Department, New York State Psychiatric Institute.
32. Telch, M. J., Agras, W. S., Taylor, C. B., Roth, W. T., & Gallen, C. (1985). Combined pharmacological and behavioral treatment for agoraphobia. Behaviour Research and Therapy, 23, 325-335.
33. Wells, A., Clark, D. M., Salkovskis, P., Ludgate, J., Hackmann, A., & Gelder, M. (1995). Social phobia: The role of in-situation safety behaviors in maintaining anxiety and negative beliefs. Behavior Therapy, 26, 153-161.